MSP Recovery Reverse Split Sparks 35% Stock Surge Amid Warrant Filings

Introduction

MSP Recovery Inc. (NASDAQ: MSPR), founded in 2014 and headquartered in Miami, Florida, specializes in Medicare, Medicaid, commercial, and secondary-payer reimbursement recovery. The company employs data-driven software and multidisciplinary expertise to secure recoveries from parties responsible for healthcare claims originally paid by health plans.

Corporate Structure and Expertise

With 51–200 employees, MSP Recovery combines IT professionals, data analysts, accountants, physicians, and attorneys. This blend of technical, legal, and clinical skill sets underpins its proprietary analytics platform, enabling the identification and resolution of misallocated claim payments dating back up to six years. The leadership team, including managing partners with health-data and regulatory experience, supports relationships across healthcare and legal sectors.

Healthcare reimbursement by The New York Public Library

Developments and News

• On August 28, 2025, MSP Recovery announced a 1-for-7 reverse stock split to comply with Nasdaq’s $1.00 minimum bid price rule.
• The split became effective at 11:59 PM ET on September 1, 2025, reducing the outstanding Class A common stock to approximately 1.02 million shares.
• On October 28, 2025, the company filed three Prospectus Supplements (Rule 424(b)(3)) covering:
  • Up to 909,982 shares of Class A common stock and 755,200,000 related warrants (including 236,019 shares underlying warrants).
  • 32,220 shares of Class A common stock (15,239 issuable upon exercise of CPIA warrants at $0.4375 per share).
  • 56,896 shares of Class A common stock (warrants exercisable at $0.0175 per share under VRM and VRP agreements).
• On November 4, 2025, MSPR closed at $0.7031 per share, reflecting a 35.08% increase, with trading volume of 34,238,152 shares.

Financial and Strategic Analysis

The reverse split was intended to satisfy Nasdaq Capital Market Rule 5450(a)(1) by raising the bid price threshold. As of November 4, 2025, the closing price was $0.7031, while warrant exercise prices—$0.4375 for public warrants and $0.0175 for VRM/VRP warrants—indicate potential limitations on immediate proceeds, given market price fluctuations. Management does not anticipate relying on warrant exercises for operational funding, opting to draw on existing cash reserves instead. Equity issuances under service agreements suggest a strategy to manage obligations and maintain key partnerships.

Market Position and Industry Context

MSP Recovery operates within the healthcare reimbursement-recovery niche, competing based on advanced analytics and legal expertise. Its business model addresses the demand from health plans and providers to reclaim incorrectly paid claims. The firm’s use of proprietary software and multidisciplinary teams positions it among peers focusing on cost-recovery and payment-accuracy solutions within the healthcare technology sector.

tl;dr

On August 28, 2025, MSP Recovery announced a 1-for-7 reverse stock split effective September 1 to meet Nasdaq’s $1.00 bid requirement. The company filed prospectus supplements on October 28, 2025, for share and warrant offerings under existing agreements. As of November 4, 2025, MSPR shares increased by 35.08% to $0.7031 amid 34.2 million shares traded, while management indicated a preference for funding through cash reserves rather than warrant exercises.